v3.19.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Cash flows from operating activities:    
Net income (loss) $ 1,472,373 $ (669,646)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation 1,408 3,103
Amortization 24,239 23,757
Amortization of debt discount 25,000
Gain on sale of intangible asset (150,000)
Gain on debt settlement (34,925)
Gain on restructuring of service-related obligations (1,580,167)
Changes in operating assets and liabilities    
(Increase) decrease in accounts receivable (2,836) 8,391
Increase in inventory (7,622) (4,426)
Decrease in other current assets 2,776 1,742
Increase in accounts payable 119,061 205,877
Increase in accounts payable, related parties 6,233 4,214
Increase in accrued royalties 1,409 1,373
Increase in accrued payroll 54,386
Increase in notes payable, related parties 20,000
Increase in notes payable, related parties, convertible 70,000
Increase in contract liability 8,166 99,722
Increase in other current liabilities 68,707
Net cash used in operating activities (139,885) (87,800)
Cash flows from investing activities:    
Proceeds from sale of intangible asset 150,000
Net cash provided in investing activities 150,000
Cash flows from financing activities:    
Proceeds from sale of common stock 50,000
Proceeds from issuance of notes payable, related parties 20,000
Proceeds from issuance of notes payable, related parties, convertible 70,000
Net cash provided by financing activities 140,000
Net increase in cash and cash equivalents 10,115 52,200
Cash and cash equivalents, beginning of period 1,821 3,179
Cash and cash equivalents, end of period 11,936 55,379
Supplemental cash flow information:    
Interest paid
Cash paid for income taxes
Schedule of Non-Cash Investing and Financing Activities:    
Issuance of common stock for notes payable, related parties, convertible 55,237
Issuance of common stock as consideration for accounts payable 29,000
Conversion of notes payable to preferred stock $ 2,099,389